Skip to content

Ulipristal

  • Prescription medicine
  • Prescription only
  • Identity checked
  • Sources last checked 2026-09-04

This page shows what was measured, who it was measured in, and what that does not settle.

What Ulipristal does in the body

Prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure [see Dosage and Administration (2

From the FDA-approved label: When taken immediately before ovulation is to occur, ella postpones follicular rupture. The likely primary mechanism of action of ulipristal acetate for emergency contraception is therefore inhibition or delay of ovulation; however, alterations to the endometrium that may affect implantation may also contribute to efficacy.

What happened in people

RNAWiki has not yet published a reviewed conclusion for this use.

A fixed RNAWiki sentence

Where this came from

Wording RNAWiki always uses, not a finding about this substance.

No reviewed claim names a result for any goal on this record.

No source is stored against this line.

The limit that matters most

Not recorded.

Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
Professional supervision is normally required. A regulator classifies this substance in a way that restricts how it is supplied.

What the registries record it as

  • The substance registry classes this as chemical.

    FDA substance registry · 6J5J15Q2X8 · read 2026-08-29

Where each sentence above came from

No recorded sentence describes the change this makes in a way that stands on its own. The page opens with what it is taken for instead, and the recorded explanation follows below.

Shown as the opening line on this page.

No statement of the main limit is recorded.

The four opening statements run to 80 words.

Words this page uses

Four words worth knowing first

Chosen from what this page shows, with each one explained before the word it depends on.

Biomarker

A biomarker is a number from a test that stands in for something about health.

A picture of it, and where the picture fails

A biomarker is like a fuel gauge.

Where that stops being true. A gauge is wired to the tank. Many biomarkers are only loosely tied to health.

What people get wrong. A better number is read as a better life. Several medicines improved a number and helped nobody.

A measurable indicator used as a substitute for a clinical outcome of interest.

Stand-in result

A stand-in result is a number measured because the real result takes too long.

A picture of it, and where the picture fails

It is like judging a journey by the speedometer rather than by arriving.

Where that stops being true. Speed does predict arrival. Many stand-in results do not predict the real one.

What people get wrong. A stand-in result is often reported as the result itself.

A surrogate endpoint substituted for a clinical endpoint, valid only where the substitution has been shown to hold.

What happened in peopleRead from sources, not yet reviewed

What happened in people

Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.

Number of Participants With Pregnancy

The study did not show it

Who was studied
NCT00551616
How many people
2221
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Pregnancy (efficacy)

The study did not show it

Who was studied
NCT00271583
How many people
1672
Study design
Phase 2/Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Pregnancy Rate

The study did not show it

Who was studied
NCT00411684
How many people
1623
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Proportion of Dosing Instances Among User Population Taken Within 120 Hours (5 Days) of Most Recent Episode of Unprotected Sex.

The study did not show it

Who was studied
NCT03208985
How many people
1270
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Time to positive COVID-19 disease

The study did not show it

Who was studied
NCT04352933
How many people
1000
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot

Pregnancy rate

The study did not show it

Who was studied
NCT06727734
How many people
980
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.

What happened in peopleRead from sources, not yet reviewed

How close this is to real life

The top step is something a person would feel or care about. The bottom is a guess from software. Filled steps are where evidence exists for this substance.

  1. Living longer, or avoiding a major event No evidence recorded. Death, a heart attack, a stroke, a hospital stay.No registered study measures this.
  2. What a body can do day to day No evidence recorded. Walking, dressing, breathing, recovering.No registered study measures this.
  3. Measured performance No evidence recorded. How much was lifted, how far was run, how fast.No registered study measures this.
  4. Symptoms and quality of life No evidence recorded. Pain, tiredness, mood, sleep, as the person rated it.No registered study measures this.
  5. A number that stands in for health Evidence recorded. Cholesterol, blood sugar, bone density. A stand-in, not the thing itself.1 registered measure of this kind.
  6. A step measured inside a person Evidence recorded. Something measured in human tissue or human cells.A human record sits on the stored organism ladder.
  7. Animals No evidence recorded. Mice, rats, dogs. Useful for ideas, not proof about people.No animal record is stored.
  8. Cells in a dish Evidence recorded. Cells or chemistry on a bench, far from a whole body.Stored mechanism abstracts describe steps measured in cells or tissue.
  9. A guess from software No evidence recorded. Nobody measured it. RNAWiki never publishes one as a finding.RNAWiki stores no prediction for this record. Software can suggest a link. RNAWiki does not publish one as a finding.

Higher on these steps means closer to something a person would feel. It does not mean better done.

What it would be like to takeRead from sources, not yet reviewed

Felt, measured, or meaningful

Three different things that get called the same word. Registered studies measured all three, and mixing them is how a blood test becomes a health claim.

Felt

Things a person could notice without a test.

No registered study measured anything of this kind.

Measured

Things only a test, a scale or a device shows.

  • hemoglobin levels

Meaningful

Things that change how a life goes, not only a number.

No registered study measured anything of this kind.

A registered study says what someone planned to measure. It does not say what they found. A number moving is not the same as a life going better. The two are shown apart here.

Felt, but not shown to help. A person notices a change. No study showed it leads anywhere good.

Measured, but not felt. A number moves. The person notices nothing. Both can be true.

Measured, but not shown to matter. A number moves in the good direction. Nobody showed that lives went better.

Matters, but takes years. The result that counts may take longer than anyone would keep watching.

Names that fit none of the three (22)
  • efficacy endpoints
  • pregnancy following emergency contraception
  • ovulation inhibition
  • blood loss during surgery
  • restored uterine cavity 1 year after enrollment
  • operative time
  • endometrial thickness
  • amenorrhea
  • pregnancies prevented
  • ongoing pregnancy
  • clinical pregnancy
  • ovulatory disruption
  • satisfied the advance provision model
  • who would recommend the advance provision model to a friend
  • ongoing pregnancy rates
  • ovulation implant alone
  • ovulation implant and same day upa
  • induction to abortion interval time
  • recruited to study protocol
  • adherent to study protocol

These are harms, study-process measures, or names the rules did not recognise. They are shown rather than dropped.

What is missing or unclearRead from sources, not yet reviewed

Were people like you studied?

RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.

Who was studied

People similar to this profile were included.

  • Ella is a progesterone agonist/antagonist emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure [see Dosage and Administration (2.1) ]. E lla is not intended for routine use as a contraceptive.

Who is missing from the studies

  • Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What the label states about particular groups

  • On pediatric, the label states: “There is no relevant use of ulipristal acetate for children of prepubertal age in the indication emergency contraception .”

    US prescribing information · e5f09468-7ac8-40ba-a85b-758a32f586c3 · read 2026-08-30

  • On older people, the label states: “This product is not intended for use in postmenopausal women.”

    US prescribing information · e5f09468-7ac8-40ba-a85b-758a32f586c3 · read 2026-08-30

  • On people who are pregnant, the label states: “Risk Summary Ella is contraindicated for use during an existing or suspected pregnancy.”

    US prescribing information · e5f09468-7ac8-40ba-a85b-758a32f586c3 · read 2026-08-30

  • On people who are breastfeeding, the label states: “Risk Summary Ulipristal acetate and its active metabolite, monodemethyl-ulipristal acetate, are present in human milk in small amounts (see Data ).”

    US prescribing information · e5f09468-7ac8-40ba-a85b-758a32f586c3 · read 2026-08-30

  • On people with reduced liver function, the label states: “No studies have been conducted to evaluate the effect of hepatic disease on the disposition of ella .”

    US prescribing information · e5f09468-7ac8-40ba-a85b-758a32f586c3 · read 2026-08-30

  • On people with reduced kidney function, the label states: “No studies have been conducted to evaluate the effect of renal disease on the disposition of ella .”

    US prescribing information · e5f09468-7ac8-40ba-a85b-758a32f586c3 · read 2026-08-30

Where the result stopped carrying

  • This is a scope explorer, not a diagnosis engine.
  • It shows who was studied so you can see whether people similar to you were included.

RNAWiki cannot tell whether a study fits you. It can show who was in it.

What it would be like to takeRead from sources, not yet reviewed

Why it might seem to do nothing

A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.

It was studied for a different goal

The studies measured something else entirely.

On this record: Some registered studies measured things that match no goal on this page.

It was studied in different people

The people in the studies were not much like the reader.

On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

The evidence may simply be wrong

Small early studies often do not hold up.

On this record: RNAWiki has not yet published a reviewed conclusion for this use.

Other reasons RNAWiki checked and found nothing for (10)
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.

None of these is a reason to take more. Taking more is not a step this page ever suggests.

What it would be like to takeRead from sources, not yet reviewed

What taking it involves

The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.

How it is supplied

Prescription only

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Read from the recorded approval status.

No source is stored against this line.

Form and route

Oral

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form and route recorded on this substance.

No source is stored against this line.

Who oversees it

Professional supervision is normally required. A regulator classifies this substance in a way that restricts how it is supplied.

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Suppression classes recorded: S1.

No source is stored against this line.

What is in the pack

Sold as tablet, given by the oral route.

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

Recorded notes on how this is sold and what that means for what is in the pack.

No source is stored against this line.

Where it is registered

Regulatory records are listed in the technical disclosure at the foot of this page.

Counted from records

Where this came from

A count of rows RNAWiki holds. It describes our records, not your body.

Register entries are stored per jurisdiction and shown with their dates.

No source is stored against this line.

Why people stop

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No record of why people stopped taking it is stored for this substance.

No source is stored against this line.

What it would be like to takeNothing found in the sources checked

What can go wrong

Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.

Nothing found in the sources checked

No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Reports sent to a regulator

  • These are reports people sent to a regulator. They do not show the medicine caused the reaction.
  • Nobody counted how many people took the medicine and reported nothing.
  • The same event can be reported more than once, and many reports are incomplete.
  • News coverage, lawsuits and new warnings change how often people report.
  • A count is not a rate and not a risk.

Ulipristal appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 98 reaction mentions were counted. One report can name several reactions.

The recorded terms (10)
  • unintended pregnancy — 36 reaction mentions
  • abortion spontaneous — 22 reaction mentions
  • vaginal haemorrhage — 17 reaction mentions
  • abortion induced — 5 reaction mentions
  • premature delivery — 4 reaction mentions
  • abortion missed — 3 reaction mentions
  • abortion threatened — 3 reaction mentions
  • chorioretinopathy — 3 reaction mentions
  • uterine leiomyoma — 3 reaction mentions
  • cleft lip and palate — 2 reaction mentions
  • open-targets-adr · recorded 2026-06-24 · a recorded source, not a stored snapshot

Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.

Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What is missing or unclearRead from sources, not yet reviewed

Does the exact form matter?

Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.

The form that was studied

Oral

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form used in the studies cited on this page.

No source is stored against this line.

What is sold

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing further is recorded about which forms are sold.

No source is stored against this line.

What is recorded as being sold

  • 5 products list this as an active ingredient in the United States drug directory. 5 of them contain it and nothing else.

    FDA National Drug Code directory · 73302-456 · read 2026-08-29

  • They are sold as powder and tablet, taken oral.

    FDA National Drug Code directory · 73302-456 · read 2026-08-29

  • The regulator's established pharmacologic class for it is progesterone agonist/antagonist [epc] and selective progesterone receptor modulators [moa].

    FDA National Drug Code directory · 73302-456 · read 2026-08-29

  • 2 published labels name it as an active ingredient. 2 of them describe this substance alone, which is where its own label text on this page comes from.

    US prescribing information · e5f09468-7ac8-40ba-a85b-758a32f586c3 · read 2026-08-29

  • Those labels are classed as human prescription drug.

    US prescribing information · e5f09468-7ac8-40ba-a85b-758a32f586c3 · read 2026-08-29

  • Ella is oral at 3 DOSAGE FORMS AND STRENGTHS The ella tablet is supplied as a white to off-white, round, curved tablet containing 30 mg of ulipristal acetate and is marked " ella " on both sides. 30 mg tablet ( 3 ), recorded as fda label in effect 2023-02-06 in the United States.

    US prescribing information · e5f09468-7ac8-40ba-a85b-758a32f586c3 · read 2026-08-30

Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.

What it would be like to takeRead from sources, not yet reviewed

What you could measure

This one is decided with a clinician, so this section holds questions to ask rather than a plan to run.

Self-experiment planning is not offered for a prescription or clinician-supervised medicine. The questions below are for a clinician or pharmacist.

Questions worth asking

  • Which of the trials of Ulipristal studied people like me?
  • What was measured, and for how long?
  • Was the result a laboratory value or a health outcome?
  • What would we watch for, and when would we stop?

Tracking can show whether something changed for you. It cannot show what caused it.

RNAWiki records evidence. It does not say whether this substance is right for you.

What is missing or unclearRead from sources, not yet reviewed

What nobody knows yet

Open questions, each with why it is open and what would close it.

Missing populations

Which groups were under-represented in the studies has not been recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing long-term data

No completed tested study window is recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

No reviewed conclusion

RNAWiki has not yet published a reviewed conclusion for this use.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing interaction studies

No interaction was found in the registers checked. Not finding one is not the same as showing there is none.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Formulation uncertainty

Several salts, forms or products of Ulipristal are recorded. Results from one form may not transfer to another.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Mechanism not reviewed

No reviewed mechanism story exists for this substance.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

What happened in peopleRead from sources, not yet reviewed

Check any of this yourself

Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.

How many documents were read

  • 2 documents were read for this substance.

    RNAWiki source record

  • 2 of them state the same tMax, and they agree.

    RNAWiki source record

Where else this substance is registered

FDA substance identifier (UNII)
6J5J15Q2X8
CAS registry number
159811-51-5
PubChem compound
13559281
ChEMBL
CHEMBL2103846
WHO international nonproprietary name list entry
8367
RxNorm concept
1005921
EMA substance identifier
100000093430
DrugBank
DB08867

Checks this page had to pass

  • Passed

    Identity resolved

    no open identity hold

  • Passed

    No unresolved merge across substance families

    no quarantine open

  • Passed

    Every public sentence names a source

    The opening statement carries the origin: Written into the record, not signed off.

  • Not passed

    Trial roles classified for highlighted evidence

    No registered study is classified as testing this substance.

  • Passed

    No internal keys in reader text

    enforced by the copy-contract test over the rendered page

  • Passed

    Safety mode resolved

    Suppression classes recorded: S1.

  • Passed

    Canonical metadata present

    slug and display name present

What is missing or unclearRead from sources, not yet reviewed

How this medicine reached us

Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.

What the approval register records

  • 2 approved applications cover products containing this substance. The earliest was NDA022474, approved 20100813 to LAB HRA PHARMA.

    Drugs@FDA application register · NDA022474 · read 2026-08-29

  • Marketing status on the register: prescription.

    Drugs@FDA application register · NDA022474 · read 2026-08-29

  • The earliest marketing start date recorded for a listed product is 20130712.

    FDA National Drug Code directory · 73302-456 · read 2026-08-29

What is missing or unclearRead from sources, not yet reviewed

What to learn next

Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.

This order is fixed in code and does not count clicks or time on the page.

What is not here

7 questions this page could not answer

These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.

  • What was measured, goal by goal — found nothing in the sources checked.
  • The path through the body — found nothing in the sources checked.
  • How long anything takes — found nothing in the sources checked.
  • What it may clash with — found nothing in the sources checked.
  • Other ways to the same goal — found nothing in the sources checked.
  • Claims that go past the evidence — found nothing in the sources checked.
  • What changed on this page — found nothing in the sources checked.

The record as stored

The full record, for auditing

Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.

Recorded evidence blocks (10)

What did Ulipristal's largest trial (980 people) and its longest (10 years) measure?


980 people in Ulipristal's largest registered study, 10 years in its longest registered window, measuring Changes in Glycodelin-A endometrial expression pattern and Progesterone serum levels in women expose to ulipristal acetate on stimulated ovarian cycles for FIV. ClinicalTrials.gov · 2026-09-01

20 phase4, 11 phase3, 9 phase2, 6 na or unstated, 6 phase1, 2 early phase1, 2 na; NCT04028986; 2026-06-01; no ageing endpoint recorded. Last human test completed 2024, NCT05285605.

Interpretation These counts include studies where Ulipristal was a comparison treatment, a background treatment or an exposure in an observational study, and the longest window may be a planned end date. Trial roles have not yet been classified for this record.

Show the evidence
  • phase4
    20
  • phase3
    11
  • phase2
    9
  • na or unstated
    6
  • phase1
    6
  • early phase1
    2
2 more recorded rows
  • na
    2
  • Last recorded human test NCT05285605
    2024-01-22

recorded 2026-09-01 · last checked 2026-09-04

Ulipristal was tested only in human — what did it show?


human: biomarker (55): the rungs where Ulipristal has a recorded finding. Europe PMC and ClinicalTrials.gov · organism ladder · 2026-09-01

Interpretation Changes in Glycodelin-A endometrial expression pattern and Progesterone serum levels in women expose to ulipristal acetate on stimulated ovarian cycles for FIV — the recorded outcome words.

Yeast C. elegans Drosophila Mouse Rat Dog Non-human primate Human biomarker
Show the evidence
  • human NCT01391845
    biomarker; Changes in Glycodelin-A endometrial expression pattern and Progesterone serum levels in women expose to ulipristal acetate on stimulated ovarian cycles for FIV; 55

recorded 2026-09-01 · last checked 2026-09-04

10 of Ulipristal's trials stopped: accrual/recruitment, other?


accrual/recruitment (1) and other (9): Ulipristal's stop wording, clustered. ClinicalTrials.gov · 2026-09-01

"Lack of availibility of eligible subjects"; 10 of 55 registered studies

Show the evidence

Trial

  • NCT02425878
    terminated; "Lack of availibility of eligible subjects"
  • NCT02825719
    terminated; "Ulipristal was withdrawal from the market"
  • NCT03027973
    withdrawn; "PI made the decision to not continue the study. It was at the Health Canada review stage."
  • NCT03296098
    withdrawn; "withdrawn due to FDA feedback"
  • NCT03325868
    withdrawn; "IND issues"
  • NCT03342859
    terminated; "Due to findings in the preclinical carcinogenicity studies for vilaprisan (BAY1002670)"
4 further recorded trials
  • NCT03537768
    terminated; "We weren't seeing as many pregnancies we initially thought."
  • NCT03829696
    withdrawn; "The study is not proceeding at this time."
  • NCT04004884
    terminated; "Lack of recruitment"
  • NCT04132349
    terminated; "Ulipristal Acetate was recalled"

recorded 2026-09-01 · last checked 2026-09-04

Human studies of Ulipristal used ulipristal acetate 20 mg — over how long?


studies of Ulipristal used the recorded amount. ClinicalTrials.gov · 2026-09-01

6 recorded entries; human; also "ulipristal acetate 20 mg", "ulipristal acetate 10 mg", "Ulipristal Acetate 30 MG Oral Tablet"

Show the evidence

human

  • NCT00290251
    ulipristal acetate 20 mg
  • NCT00290251
    ulipristal acetate 10 mg
  • NCT03354117
    Ulipristal Acetate 30 MG Oral Tablet
  • NCT03829696
    ella® (ulipristal acetate emergency contraception 30 mg)
  • NCT04028986
    Ulipristal Acetate 5 MG Oral Tablet
  • NCT04132349
    Ulipristal Acetate 5 mg

recorded 2026-09-01 · last checked 2026-09-04

Which of Ulipristal's 3 ongoing trials reports first?


3 registered trials of Ulipristal are open; earliest completion 2027-10. ClinicalTrials.gov · 2026-09-01

Delay in follicular rupture; Pregnancy rate; latest 2027-12-31

Show the evidence

Trial

  • NCT05674513
    "Disparities in Emergency Contraceptive Metabolism Dictate Efficacy"; n 140; "Delay in follicular rupture"; 2027-12-31
  • NCT06727734
    "Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception"; n 980; "Pregnancy rate"; 2027-10
  • NCT07434128
    "Mammogram Pretreatment With Ulipristal Acetate"; n 26; "Difference in percent dense area"; 2027-12-31

recorded 2026-09-01 · last checked 2026-09-04

Which 14 trials of Ulipristal posted no result?


Posted no result
14 of 14 completed trials
Registrations
NCT01156857, NCT01252069, NCT01953679, NCT02465814, NCT02634437 and NCT03349190, and 8 more
Completion dates
oldest 2012-02; newest 2024-01-22
Show the evidence

Trial

  • NCT01156857
    2012-02
  • NCT01252069
    2014-01
  • NCT01953679
    2015-11
  • NCT02465814
    2016-10
  • NCT02634437
    2016-12-09
  • NCT03349190
    2019-01-08
8 further recorded trials
  • NCT03354117
    2019-05-31
  • NCT02922127
    2019-10-21
  • NCT04989400
    2020-01-01
  • NCT02587000
    2020-03-17
  • NCT03802149
    2020-04-02
  • NCT04832906
    2021-03-13
  • NCT02408770
    2023-01-25
  • NCT05285605
    2024-01-22

At the median, Ulipristal's trials enrolled 40 people — anything larger?


Median enrolment
40
Largest enrolment
980
Registered trials counted
55

What do 98 spontaneous reports say about Ulipristal — and not say?


These are reports people sent to a regulator. They do not show the medicine caused the reaction. Nobody counted how many people took the medicine and reported nothing. The same event can be reported more than once, and many reports are incomplete. News coverage, lawsuits and new warnings change how often people report. A count is not a rate and not a risk.

Ulipristal appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 98 reaction mentions were counted: unintended pregnancy 36; abortion spontaneous 22; vaginal haemorrhage 17; abortion induced 5. open-targets-adr · CHEMBL2103846 · 2026-06-24

Show the evidence
  • unintended pregnancy
    36
  • abortion spontaneous
    22
  • vaginal haemorrhage
    17
  • abortion induced
    5
  • premature delivery
    4
  • abortion missed
    3
4 more recorded rows
  • abortion threatened
    3
  • chorioretinopathy
    3
  • uterine leiomyoma
    3
  • cleft lip and palate
    2

recorded 2026-06-24 · last checked 2026-09-04

Ulipristal and CYP3A4, P-GP and BCRP: shared by which compounds?


CYP3A4, P-GP and BCRP appear in Ulipristal's recorded interaction sentences, 4 in all. openfda-label+europepmc · 2026-08-30

Interpretation pharmacokinetics

Show the evidence

CYP3A4

  • pharmacokinetics
    In vitro data indicate that this is predominantly mediated by CYP3A4.
  • pharmacokinetics
    Drug interactions CYP3A4 inducers: When a single 30 mg dose of ulipristal acetate was administered following administration of the strong CYP3A4 inducer, rifampin 600 mg once daily for 9 days, C max and AUC of ulipristal acetate decreased by 90% and 93% respectively.
  • pharmacokinetics
    CYP3A4 inhibitors: When a single 10 mg dose of ulipristal acetate was administered following administration of the strong CYP3A4 inhibitor, ketoconazole 400 mg once daily for 7 days, C max and AUC of ulipristal acetate increased by 2- and 5.9- fold, respectively.
  • pharmacokinetics
    There was no in vivo drug-drug interaction study between ulipristal acetate 30 mg and CYP3A4 inhibitors [see Drug Interactions (7.1) ] .

recorded 2026-08-30 · last checked 2026-09-04

What is recorded about Ulipristal and autophagy?


"IL-1β, IL-18 and activated caspase-1 production was evaluated by the Automated Immunoassay System (ELLA); ASC speck formation (a marker of NLRP3 activation) was analyzed by FlowSight Imaging flow-cytometer (AMNIS); the expression of autophagy targets was investigated by RT-PCR and Western blot (WB); and the modulation of…" — where Ulipristal and autophagy appear together. Europe PMC · pathway abstract search · 2023-12-13

autophagy, IGF-1; PMID 38139851, 39050181

Show the evidence
  • autophagy PMID 38139851
    "IL-1β, IL-18 and activated caspase-1 production was evaluated by the Automated Immunoassay System (ELLA); ASC speck formation (a marker of NLRP3 activation) was analyzed by FlowSight Imaging flow-cytometer (AMNIS); the expression of autophagy targets was investigated by RT-PCR and Western blot (WB); and the modulation of autophagy-related up-stream signaling pathways and Tau phosphorylation were…"
  • IGF-1 PMID 39050181
    "A retrospective cohort study was performed to evaluate and compare tumor necrosis factor α (TNF-α), insulin-like growth factor 1 (IGF-1), plasminogen activator inhibitor-1 (PAI-1) serum concentrations in patients with UFs without prior hormonal treatment, patients with UFs treated with a 3-month standard ulipristal acetate (UPA - a type of selective progesterone receptor modulator) scheme (5…"

recorded 2023-12-13 · last checked 2026-09-04

Where it is registered
Identifiers, relations and other names

The exact record

ChEMBL id
CHEMBL2103846
PubChem CID
13559281
CAS number
159811-51-5
RxCUI
1005921
InChIKey
HKDLNTKNLJPAIY-WKWWZUSTSA-N
Also called
Uliprisnil, upa, 11β-[4-(Dimethylamino)phenyl]-17-hydroxy-19-norpregna-4,9-diene-3,20-dione, ULIPRISTAL ACETATE ULIPRISTAL [MI], ULIPRISTAL [EMA EPAR], ULIPRISTAL [USAN], ULIPRISTAL [VANDF], Ulipristal [WHO-DD], ulipristal [INN]
Salt form
Ulipristal acetate ulipristal, ulipristal acetate
Trade name
Ella, Logilia, Ella / Logilia, Esmya
Sources (10)

Sources

4 more sources
  • open-targets-adr CHEMBL2103846 ·
  • openfda-label 2bf93d23-cddd-4613-9066-5b5fa090404b ·
  • openfda-label+europepmc K1:6J5J15Q2X8 ·
  • national registers US, EU, CA ·

ChEMBL ATC CC BY-SA · ClinicalTrials.gov — US Government work · Europe PMC — metadata only, under the recorded legal gate · Open Targets 26.06 — CC0 · derived from this page's own recorded fields; no external licence · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md · openFDA / DailyMed — US Government work

How these records are assembled · Which registers were checked

Index-quality checks
  • identity passed: no open identity hold
  • required summary fields resolved: 5 required field(s) not terminal: Why people use it, Best-supported result, Most important common problem, Biggest unanswered question, Human evidence
  • public claims reviewed: 0 reviewed claim(s); drafts are never rendered
  • source coverage passed: 10 source rows
  • no critical contamination: no quarantine open
  • canonical metadata passed: slug and display name present
  • no raw internal fields: enforced by the copy-contract test over the rendered page

This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.